Phibro Animal Health | PAHC - Ebitda


Phibro Animal Health reported $68.1M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Align Technology USD 260.87M 77.03M Dec/2025
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 18.48M 3.11M Dec/2025
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Canopy Growth CAD -2.87M 19.49M Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Eli Lilly USD 12.14B 4.26B Dec/2025
Henry Schein USD 289M 2M Mar/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Merck USD 6.3B 2.09B Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Pacira USD 40.24M 1.53M Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Supernus Pharmaceuticals USD 29.23M 19.27M Mar/2026
Zoetis USD 939M 101M Dec/2025